Driver: Expanding manufacturing capacity Restraint: Stringent cost and payer controls Opportunity: Increasing studies on oral GLP-1 Challenge: Counterfeits and compounded GLP-1 gray market
The findings appeared on July 22, 2025 in BMJ Open Diabetes Research & Care Given the severe societal, familial, and economic burden of diabetes-related dementia, these findings raise important considerations about the role of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management, the authors said
While standardized clinical dosing for IGF-1 LR3 in humans remains under study, preclinical and pharmacokinetic data 2 provide a safe, guided framework for how it behaves in the body
Deep TMS has been proven to be safe, noninvasive, and effective, without causing any long-term adverse effects
B12 injection shots can usually be felt within 24 hours (and a change should show in blood tests after a month or two) A high dose of B12 oral supplementation takes the same time as an injection: roughly 24 hours to feel an improvement and then up to 2 months to show in blood markers